Intellectual Property


Mark Nickas is an associate in Brown Rudnick’s Intellectual Property Practice Group in the Boston office. His practice focuses on patent counseling, including preparation and prosecution of patent applications and providing opinions on infringement and validity, for clients in the life sciences. Mark has experience in biotechnology, pharmaceuticals, medical devices, materials science and mechanical devices.

Prior to becoming an attorney, Mark did molecular biology research at academic institutions and at a large pharmaceutical company. During law school, Mark worked as an intern in the legal departments of a biotechnology company and a non-profit research institution. As a patent attorney, Mark has worked as an associate for other law firms and as an internal counsel for the technology transfer office of a large research university.


Boston University School of Law – J.D., concentration in Intellectual Property, honors
University of California, San Diego – Ph.D., biology
Northwestern University – B.A., biochemistry, molecular biology and cellular biology

Bar Admissions

US Patent and Trademark Office
Nickas, M. (2015). Federal Circuit delays launch of first U.S. biosimilar. Mass. Lawyers Weekly. Sept. 7, 2015.
Nickas, M. (2015). SCOTUS decisions show patent eligibility erosion trend. New Hampshire Bar Association News, 26(1), 28.
Nickas, M. (2012). Discordant Harmonization: Did the European Court of Justice interpret the Biotechnology Directive’s exclusions to patentability too broadly in Brüstle v. Greenpeace? American Intellectual Property Law Association Quarterly Journal, Fall 2012.
Nickas, M. (2012). A patent prize system to promote development of new antibiotics and conservation of existing ones. Pittsburgh Journal of Technology Law and Policy, 12(5).
Mathieson, E.M., Suda, Y., Nickas, M., Snydsman, B., Davis, T.N., Muller, E.G.D., and Neiman, A.M. (2010). Vesicle docking to the spindle pole body is necessary to recruit the exocyst during membrane formation in Saccharomyces cerevisiae. Molecular Biology of the Cell, 21, 3693-3707.
Nickas, M.E., Diamond, A.E., Yang, M., and Neiman, A.M. (2004). Regulation of spindle pole function by an intermediary metabolite. Molecular Biology of the Cell, 15, 2606-16.
Nickas, M.E., Schwartz, C., and Neiman, A.M. (2003). Ady4p and Spo74p are components of the meiotic spindle pole body that promote growth of the prospore membrane in Saccharomyces cerevisiae. Eukaryotic Cell, 2, 431-45.
Nickas, M.E., and Neiman, A.M. (2002). Ady3p links spindle pole body function to spore wall synthesis in Saccharomyces cerevisiae. Genetics, 160, 1439-50.
Bajgier, B.K., Malzone, M., Nickas, M., and Neiman, A.M. (2001). SPO21 is required for meiosis-specific modification of the spindle pole body in yeast. Molecular Biology of the Cell, 12, 1611-21.
Nickas, M.E., Bernard, A., and Kazlauskas, A. (2001). The requirement of tyrosines 579 and 581 for maximal ligand-dependent activation of the βPDGFR is influenced by noncytoplasmic regions of the receptor. Experimental Cell Research, 265, 80-89.
Nickas, M.E., and Yaffe, M.P. (1996). BRO1, a novel gene that interacts with components of the Pkc1p-mitogen-activated protein kinase pathway in Saccharomyces cerevisiae. Molecular and Cellular Biology, 16, 2585-93.
Speaking Engagements
EMBO Conference, Heidelberg, Germany
Cold Spring Harbor Laboratory Meeting, New York
Professional Affiliations
Boston Patent Law Association